Clinical Study Results
Research Sponsor: Pearl Therapeutics, Inc.
Medicines Studied: Budesonide and Formoterol Fumarate
Study Title: A study to learn how different treatments of budesonide and formoterol fumarate affect the lung function of participants with moderate to very severe COPD

Thank you!
Thank you to the participants who took part in this clinical study for the study medicines budesonide and formoterol fumarate. You and all of the participants helped researchers learn more about treatments of budesonide and formoterol fumarate taken together to help people with moderate to very severe chronic obstructive pulmonary disease, also known as COPD.

Pearl Therapeutics, Inc. sponsored this study and thinks it is important to share the results of this study with you and the public. An independent non-profit organization called CISCRP helped prepare this summary of the study results for you. We hope it helps you understand and feel proud of your important role in medical research.

If you participated in this study and have questions about the results, please speak with the doctor or staff at your study site.

What is happening with this study now?
Each participant was in this study for between 3 months and 1 year. But, the entire study took about 2 years to finish.
This study started in May 2016 and ended in April 2018. This study included 1,876 participants in 18 countries: Argentina, Austria, Belgium, Brazil, Canada, Chile, Denmark, Germany, Italy, Mexico, Norway, Peru, Russia, South Africa, Spain, Sweden, United Kingdom, and United States.

The sponsor reviewed the data collected when this study ended and created a report of the results. This is a summary of that report.